Decreased Release of Gonadotropin-Releasing Hormone During the Preovulatory Midcycle Luteinizing Hormone Surge in Normal Women
To investigate the contribution of hypothalamic gonadotropin-releasing hormone (GnRH) secretion to the midcycle gonadotropin surge in the human, the response of luteinizing hormone (LH) to competitive GnRH receptor blockade achieved by administration of a range of doses of a pure GnRH antagonist was...
Gespeichert in:
Veröffentlicht in: | Proceedings of the National Academy of Sciences - PNAS 1994-07, Vol.91 (15), p.6894-6898 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 6898 |
---|---|
container_issue | 15 |
container_start_page | 6894 |
container_title | Proceedings of the National Academy of Sciences - PNAS |
container_volume | 91 |
creator | Hall, Janet E. Taylor, Ann E. Martin, Kathryn A. Rivier, Jean Schoenfeld, David A. Crowley, William F. |
description | To investigate the contribution of hypothalamic gonadotropin-releasing hormone (GnRH) secretion to the midcycle gonadotropin surge in the human, the response of luteinizing hormone (LH) to competitive GnRH receptor blockade achieved by administration of a range of doses of a pure GnRH antagonist was used to provide a semiquantitative estimate of endogenous GnRH secretion. The LH response to 5, 15, 50, and 150 μ g/kg s.c. of the NAL-GLU GnRH antagonist ([Ac-D-2Nal1,D-4ClPhe2,D-Pal3,Arg5, D-4-p-methoxybenzoyl-2-aminobutyric acid6,D-Ala10]GnRH, where 2Nal is 2-naphthylalanine, 4ClPhe is 4-chlorophenylalanine, and 3Pal is 3-pyridylalanine) was measured in normal women in the early and late follicular phases of the menstrual cycle, at the time of the midcycle LH surge and in the early luteal phase. LH decreased in a dose-response fashion after administration of the GnRH antagonist in all cycle phases (P < 0.0001). When this suppression was expressed as maximum percent inhibition, there was no difference in response during the early and late follicular and early luteal phases. However, at the midcycle surge, there was a leftward shift of the dose-response curve with significantly greater suppression of LH at the lower antagonist doses in comparison to the other cycle phases (P < 0.005), but no difference at the highest dose. Thus, we draw the following conclusions. (i) There is a consistently greater degree of LH inhibition by GnRH antagonism at the midcycle surge at submaximal degrees of GnRH receptor blockade than at other phases of the menstrual cycle in normal women. (ii) This leftward shift of the dose-response relationship to GnRH receptor blockade suggests that the overall amount of GnRH secreted at the midcycle surge is less than at other cycle stages. (iii) These data confirm the importance of pituitary augmentation of the GnRH signal at the time of the midcycle gonadotropin surge in the human. |
doi_str_mv | 10.1073/pnas.91.15.6894 |
format | Article |
fullrecord | <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_76623584</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>2365185</jstor_id><sourcerecordid>2365185</sourcerecordid><originalsourceid>FETCH-LOGICAL-c555t-29b64ac5ba7d72519b5371daea6cba8470774a304cb978cdc48538520eb7dfa03</originalsourceid><addsrcrecordid>eNp9kc1v1DAQxS0EKtvCmQsgiwOcsrUdO04kLqiFFmn5EB_iaDnO7NYrx17spOpy4G_H0S5L4cDJ9rzfG834IfSIkjklsjzdeJ3mDZ1TMa_qht9BM0oaWlS8IXfRjBAmi5ozfh8dp7QmhDSiJkfoqCacSlrN0M9zMBF0gg5_AjddcFjii-B1F4YYNtYXu7r1K3wZYh884PMxTs_hCvDHCOF6dHoIcYvf2c5sjQO8GAew3v64bfo8xhVg6_H7XNAOfws9-Afo3lK7BA_35wn6-ub1l7PLYvHh4u3Zq0VhhBBDwZq24tqIVstOMkGbVpSSdhp0ZVpdc0mk5Lok3LSNrE1neC3KWjACreyWmpQn6OWu72Zse-gM-CFqpzbR9jpuVdBW_a14e6VW4Vpxnrtm-_O9PYbvI6RB9TYZcE57CGNSsqpYKeoJfPYPuA5j9Hk1xQgtGZGcZeh0B5kYUoqwPMxBiZpSVVOqqqGKCjWlmh1Pbo9_4PcxZv3FXp-Mv9U_DdRydG6AmyGTT_9LZuDxDlinnOmBYGUlaP7UX2_9wok</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>201320742</pqid></control><display><type>article</type><title>Decreased Release of Gonadotropin-Releasing Hormone During the Preovulatory Midcycle Luteinizing Hormone Surge in Normal Women</title><source>MEDLINE</source><source>PMC (PubMed Central)</source><source>Alma/SFX Local Collection</source><source>Free Full-Text Journals in Chemistry</source><source>JSTOR</source><creator>Hall, Janet E. ; Taylor, Ann E. ; Martin, Kathryn A. ; Rivier, Jean ; Schoenfeld, David A. ; Crowley, William F.</creator><creatorcontrib>Hall, Janet E. ; Taylor, Ann E. ; Martin, Kathryn A. ; Rivier, Jean ; Schoenfeld, David A. ; Crowley, William F.</creatorcontrib><description>To investigate the contribution of hypothalamic gonadotropin-releasing hormone (GnRH) secretion to the midcycle gonadotropin surge in the human, the response of luteinizing hormone (LH) to competitive GnRH receptor blockade achieved by administration of a range of doses of a pure GnRH antagonist was used to provide a semiquantitative estimate of endogenous GnRH secretion. The LH response to 5, 15, 50, and 150 μ g/kg s.c. of the NAL-GLU GnRH antagonist ([Ac-D-2Nal1,D-4ClPhe2,D-Pal3,Arg5, D-4-p-methoxybenzoyl-2-aminobutyric acid6,D-Ala10]GnRH, where 2Nal is 2-naphthylalanine, 4ClPhe is 4-chlorophenylalanine, and 3Pal is 3-pyridylalanine) was measured in normal women in the early and late follicular phases of the menstrual cycle, at the time of the midcycle LH surge and in the early luteal phase. LH decreased in a dose-response fashion after administration of the GnRH antagonist in all cycle phases (P < 0.0001). When this suppression was expressed as maximum percent inhibition, there was no difference in response during the early and late follicular and early luteal phases. However, at the midcycle surge, there was a leftward shift of the dose-response curve with significantly greater suppression of LH at the lower antagonist doses in comparison to the other cycle phases (P < 0.005), but no difference at the highest dose. Thus, we draw the following conclusions. (i) There is a consistently greater degree of LH inhibition by GnRH antagonism at the midcycle surge at submaximal degrees of GnRH receptor blockade than at other phases of the menstrual cycle in normal women. (ii) This leftward shift of the dose-response relationship to GnRH receptor blockade suggests that the overall amount of GnRH secreted at the midcycle surge is less than at other cycle stages. (iii) These data confirm the importance of pituitary augmentation of the GnRH signal at the time of the midcycle gonadotropin surge in the human.</description><identifier>ISSN: 0027-8424</identifier><identifier>EISSN: 1091-6490</identifier><identifier>DOI: 10.1073/pnas.91.15.6894</identifier><identifier>PMID: 8041716</identifier><language>eng</language><publisher>United States: National Academy of Sciences of the United States of America</publisher><subject>Adolescent ; Adult ; Amino Acid Sequence ; Anatomy & physiology ; Dosage ; Dose response relationship ; Endocrinology ; Female ; Follicle Stimulating Hormone - blood ; Follicular phase ; Follicular Phase - blood ; Gonadotropin-Releasing Hormone - analogs & derivatives ; Gonadotropin-Releasing Hormone - antagonists & inhibitors ; Gonadotropin-Releasing Hormone - blood ; Hormones ; Humans ; LHRH receptors ; Luteal phase ; Luteinizing Hormone - blood ; Menstruation ; Molecular Sequence Data ; Pretreatment ; Receptors ; Receptors, LHRH - antagonists & inhibitors ; Receptors, LHRH - metabolism ; Reference Values ; Secretion ; Sex hormones ; Women</subject><ispartof>Proceedings of the National Academy of Sciences - PNAS, 1994-07, Vol.91 (15), p.6894-6898</ispartof><rights>Copyright 1994 The National Academy of Sciences of the United States of America</rights><rights>Copyright National Academy of Sciences Jul 19, 1994</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c555t-29b64ac5ba7d72519b5371daea6cba8470774a304cb978cdc48538520eb7dfa03</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://www.pnas.org/content/91/15.cover.gif</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/2365185$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/2365185$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>230,314,723,776,780,799,881,27901,27902,53766,53768,57992,58225</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8041716$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hall, Janet E.</creatorcontrib><creatorcontrib>Taylor, Ann E.</creatorcontrib><creatorcontrib>Martin, Kathryn A.</creatorcontrib><creatorcontrib>Rivier, Jean</creatorcontrib><creatorcontrib>Schoenfeld, David A.</creatorcontrib><creatorcontrib>Crowley, William F.</creatorcontrib><title>Decreased Release of Gonadotropin-Releasing Hormone During the Preovulatory Midcycle Luteinizing Hormone Surge in Normal Women</title><title>Proceedings of the National Academy of Sciences - PNAS</title><addtitle>Proc Natl Acad Sci U S A</addtitle><description>To investigate the contribution of hypothalamic gonadotropin-releasing hormone (GnRH) secretion to the midcycle gonadotropin surge in the human, the response of luteinizing hormone (LH) to competitive GnRH receptor blockade achieved by administration of a range of doses of a pure GnRH antagonist was used to provide a semiquantitative estimate of endogenous GnRH secretion. The LH response to 5, 15, 50, and 150 μ g/kg s.c. of the NAL-GLU GnRH antagonist ([Ac-D-2Nal1,D-4ClPhe2,D-Pal3,Arg5, D-4-p-methoxybenzoyl-2-aminobutyric acid6,D-Ala10]GnRH, where 2Nal is 2-naphthylalanine, 4ClPhe is 4-chlorophenylalanine, and 3Pal is 3-pyridylalanine) was measured in normal women in the early and late follicular phases of the menstrual cycle, at the time of the midcycle LH surge and in the early luteal phase. LH decreased in a dose-response fashion after administration of the GnRH antagonist in all cycle phases (P < 0.0001). When this suppression was expressed as maximum percent inhibition, there was no difference in response during the early and late follicular and early luteal phases. However, at the midcycle surge, there was a leftward shift of the dose-response curve with significantly greater suppression of LH at the lower antagonist doses in comparison to the other cycle phases (P < 0.005), but no difference at the highest dose. Thus, we draw the following conclusions. (i) There is a consistently greater degree of LH inhibition by GnRH antagonism at the midcycle surge at submaximal degrees of GnRH receptor blockade than at other phases of the menstrual cycle in normal women. (ii) This leftward shift of the dose-response relationship to GnRH receptor blockade suggests that the overall amount of GnRH secreted at the midcycle surge is less than at other cycle stages. (iii) These data confirm the importance of pituitary augmentation of the GnRH signal at the time of the midcycle gonadotropin surge in the human.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Amino Acid Sequence</subject><subject>Anatomy & physiology</subject><subject>Dosage</subject><subject>Dose response relationship</subject><subject>Endocrinology</subject><subject>Female</subject><subject>Follicle Stimulating Hormone - blood</subject><subject>Follicular phase</subject><subject>Follicular Phase - blood</subject><subject>Gonadotropin-Releasing Hormone - analogs & derivatives</subject><subject>Gonadotropin-Releasing Hormone - antagonists & inhibitors</subject><subject>Gonadotropin-Releasing Hormone - blood</subject><subject>Hormones</subject><subject>Humans</subject><subject>LHRH receptors</subject><subject>Luteal phase</subject><subject>Luteinizing Hormone - blood</subject><subject>Menstruation</subject><subject>Molecular Sequence Data</subject><subject>Pretreatment</subject><subject>Receptors</subject><subject>Receptors, LHRH - antagonists & inhibitors</subject><subject>Receptors, LHRH - metabolism</subject><subject>Reference Values</subject><subject>Secretion</subject><subject>Sex hormones</subject><subject>Women</subject><issn>0027-8424</issn><issn>1091-6490</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc1v1DAQxS0EKtvCmQsgiwOcsrUdO04kLqiFFmn5EB_iaDnO7NYrx17spOpy4G_H0S5L4cDJ9rzfG834IfSIkjklsjzdeJ3mDZ1TMa_qht9BM0oaWlS8IXfRjBAmi5ozfh8dp7QmhDSiJkfoqCacSlrN0M9zMBF0gg5_AjddcFjii-B1F4YYNtYXu7r1K3wZYh884PMxTs_hCvDHCOF6dHoIcYvf2c5sjQO8GAew3v64bfo8xhVg6_H7XNAOfws9-Afo3lK7BA_35wn6-ub1l7PLYvHh4u3Zq0VhhBBDwZq24tqIVstOMkGbVpSSdhp0ZVpdc0mk5Lok3LSNrE1neC3KWjACreyWmpQn6OWu72Zse-gM-CFqpzbR9jpuVdBW_a14e6VW4Vpxnrtm-_O9PYbvI6RB9TYZcE57CGNSsqpYKeoJfPYPuA5j9Hk1xQgtGZGcZeh0B5kYUoqwPMxBiZpSVVOqqqGKCjWlmh1Pbo9_4PcxZv3FXp-Mv9U_DdRydG6AmyGTT_9LZuDxDlinnOmBYGUlaP7UX2_9wok</recordid><startdate>19940719</startdate><enddate>19940719</enddate><creator>Hall, Janet E.</creator><creator>Taylor, Ann E.</creator><creator>Martin, Kathryn A.</creator><creator>Rivier, Jean</creator><creator>Schoenfeld, David A.</creator><creator>Crowley, William F.</creator><general>National Academy of Sciences of the United States of America</general><general>National Acad Sciences</general><general>National Academy of Sciences</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19940719</creationdate><title>Decreased Release of Gonadotropin-Releasing Hormone During the Preovulatory Midcycle Luteinizing Hormone Surge in Normal Women</title><author>Hall, Janet E. ; Taylor, Ann E. ; Martin, Kathryn A. ; Rivier, Jean ; Schoenfeld, David A. ; Crowley, William F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c555t-29b64ac5ba7d72519b5371daea6cba8470774a304cb978cdc48538520eb7dfa03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Amino Acid Sequence</topic><topic>Anatomy & physiology</topic><topic>Dosage</topic><topic>Dose response relationship</topic><topic>Endocrinology</topic><topic>Female</topic><topic>Follicle Stimulating Hormone - blood</topic><topic>Follicular phase</topic><topic>Follicular Phase - blood</topic><topic>Gonadotropin-Releasing Hormone - analogs & derivatives</topic><topic>Gonadotropin-Releasing Hormone - antagonists & inhibitors</topic><topic>Gonadotropin-Releasing Hormone - blood</topic><topic>Hormones</topic><topic>Humans</topic><topic>LHRH receptors</topic><topic>Luteal phase</topic><topic>Luteinizing Hormone - blood</topic><topic>Menstruation</topic><topic>Molecular Sequence Data</topic><topic>Pretreatment</topic><topic>Receptors</topic><topic>Receptors, LHRH - antagonists & inhibitors</topic><topic>Receptors, LHRH - metabolism</topic><topic>Reference Values</topic><topic>Secretion</topic><topic>Sex hormones</topic><topic>Women</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hall, Janet E.</creatorcontrib><creatorcontrib>Taylor, Ann E.</creatorcontrib><creatorcontrib>Martin, Kathryn A.</creatorcontrib><creatorcontrib>Rivier, Jean</creatorcontrib><creatorcontrib>Schoenfeld, David A.</creatorcontrib><creatorcontrib>Crowley, William F.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hall, Janet E.</au><au>Taylor, Ann E.</au><au>Martin, Kathryn A.</au><au>Rivier, Jean</au><au>Schoenfeld, David A.</au><au>Crowley, William F.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Decreased Release of Gonadotropin-Releasing Hormone During the Preovulatory Midcycle Luteinizing Hormone Surge in Normal Women</atitle><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle><addtitle>Proc Natl Acad Sci U S A</addtitle><date>1994-07-19</date><risdate>1994</risdate><volume>91</volume><issue>15</issue><spage>6894</spage><epage>6898</epage><pages>6894-6898</pages><issn>0027-8424</issn><eissn>1091-6490</eissn><abstract>To investigate the contribution of hypothalamic gonadotropin-releasing hormone (GnRH) secretion to the midcycle gonadotropin surge in the human, the response of luteinizing hormone (LH) to competitive GnRH receptor blockade achieved by administration of a range of doses of a pure GnRH antagonist was used to provide a semiquantitative estimate of endogenous GnRH secretion. The LH response to 5, 15, 50, and 150 μ g/kg s.c. of the NAL-GLU GnRH antagonist ([Ac-D-2Nal1,D-4ClPhe2,D-Pal3,Arg5, D-4-p-methoxybenzoyl-2-aminobutyric acid6,D-Ala10]GnRH, where 2Nal is 2-naphthylalanine, 4ClPhe is 4-chlorophenylalanine, and 3Pal is 3-pyridylalanine) was measured in normal women in the early and late follicular phases of the menstrual cycle, at the time of the midcycle LH surge and in the early luteal phase. LH decreased in a dose-response fashion after administration of the GnRH antagonist in all cycle phases (P < 0.0001). When this suppression was expressed as maximum percent inhibition, there was no difference in response during the early and late follicular and early luteal phases. However, at the midcycle surge, there was a leftward shift of the dose-response curve with significantly greater suppression of LH at the lower antagonist doses in comparison to the other cycle phases (P < 0.005), but no difference at the highest dose. Thus, we draw the following conclusions. (i) There is a consistently greater degree of LH inhibition by GnRH antagonism at the midcycle surge at submaximal degrees of GnRH receptor blockade than at other phases of the menstrual cycle in normal women. (ii) This leftward shift of the dose-response relationship to GnRH receptor blockade suggests that the overall amount of GnRH secreted at the midcycle surge is less than at other cycle stages. (iii) These data confirm the importance of pituitary augmentation of the GnRH signal at the time of the midcycle gonadotropin surge in the human.</abstract><cop>United States</cop><pub>National Academy of Sciences of the United States of America</pub><pmid>8041716</pmid><doi>10.1073/pnas.91.15.6894</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0027-8424 |
ispartof | Proceedings of the National Academy of Sciences - PNAS, 1994-07, Vol.91 (15), p.6894-6898 |
issn | 0027-8424 1091-6490 |
language | eng |
recordid | cdi_proquest_miscellaneous_76623584 |
source | MEDLINE; PMC (PubMed Central); Alma/SFX Local Collection; Free Full-Text Journals in Chemistry; JSTOR |
subjects | Adolescent Adult Amino Acid Sequence Anatomy & physiology Dosage Dose response relationship Endocrinology Female Follicle Stimulating Hormone - blood Follicular phase Follicular Phase - blood Gonadotropin-Releasing Hormone - analogs & derivatives Gonadotropin-Releasing Hormone - antagonists & inhibitors Gonadotropin-Releasing Hormone - blood Hormones Humans LHRH receptors Luteal phase Luteinizing Hormone - blood Menstruation Molecular Sequence Data Pretreatment Receptors Receptors, LHRH - antagonists & inhibitors Receptors, LHRH - metabolism Reference Values Secretion Sex hormones Women |
title | Decreased Release of Gonadotropin-Releasing Hormone During the Preovulatory Midcycle Luteinizing Hormone Surge in Normal Women |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T17%3A51%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Decreased%20Release%20of%20Gonadotropin-Releasing%20Hormone%20During%20the%20Preovulatory%20Midcycle%20Luteinizing%20Hormone%20Surge%20in%20Normal%20Women&rft.jtitle=Proceedings%20of%20the%20National%20Academy%20of%20Sciences%20-%20PNAS&rft.au=Hall,%20Janet%20E.&rft.date=1994-07-19&rft.volume=91&rft.issue=15&rft.spage=6894&rft.epage=6898&rft.pages=6894-6898&rft.issn=0027-8424&rft.eissn=1091-6490&rft_id=info:doi/10.1073/pnas.91.15.6894&rft_dat=%3Cjstor_proqu%3E2365185%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=201320742&rft_id=info:pmid/8041716&rft_jstor_id=2365185&rfr_iscdi=true |